Literature DB >> 19430666

Congenital toxoplasmosis and DALYs in the Netherlands.

L M Kortbeek1, A Hofhuis, C D M Nijhuis, A H Havelaar.   

Abstract

The calculation of disability-adjusted life years (DALYs) enables public health policy makers to compare the burden of disease of a specific disease with that of other (infectious) diseases. The incidence of a disease is important for the calculation of DALYs. To estimate the incidence of congenital toxoplasmosis (CT), a random sample of 10,008 dried blood spot filter paper cards from babies born in 2006 in the Netherlands were tested for Toxoplasma gondii-specific IgM antibodies. Eighteen samples were confirmed as positive for IgM, resulting in an observed birth incidence of CT of 1.8 cases per 1,000 live-born children in 2006 and an adjusted incidence of 2.0 cases per 1,000. This means that 388 infected children were born in 2006. The most likely burden of disease is estimated to be 2,300 DALYs (range 820-6,710 DALYs). In the previous calculations, using data from a regional study from 1987, this estimate was 620 DALYs (range 220-1,900 DALYs). The incidence of CT in the Netherlands is much higher than previously reported; it is 10 times higher than in Denmark and 20 times higher than in Ireland, based on estimates obtained using the same methods. There is no screening program in the Netherlands; most children will be born asymptomatic and therefore will not be detected or treated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19430666     DOI: 10.1590/s0074-02762009000200034

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  11 in total

Review 1.  The impact of the waterborne transmission of Toxoplasma gondii and analysis efforts for water detection: an overview and update.

Authors:  Panagiotis Karanis; Hebatalla M Aldeyarbi; Marzieh E Mirhashemi; Khalil M Khalil
Journal:  Environ Sci Pollut Res Int       Date:  2012-09-19       Impact factor: 4.223

Review 2.  The global burden of congenital toxoplasmosis: a systematic review.

Authors:  Paul R Torgerson; Pierpaolo Mastroiacovo
Journal:  Bull World Health Organ       Date:  2013-05-03       Impact factor: 9.408

3.  Observational study to assess pregnant women's knowledge and behaviour to prevent toxoplasmosis, listeriosis and cytomegalovirus.

Authors:  Monique T R Pereboom; Judith Manniën; Evelien R Spelten; François G Schellevis; Eileen K Hutton
Journal:  BMC Pregnancy Childbirth       Date:  2013-04-30       Impact factor: 3.007

4.  Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years.

Authors:  Paul R Torgerson; José E Hagan; Federico Costa; Juan Calcagno; Michael Kane; Martha S Martinez-Silveira; Marga G A Goris; Claudia Stein; Albert I Ko; Bernadette Abela-Ridder
Journal:  PLoS Negl Trop Dis       Date:  2015-10-02

Review 5.  The burden of parasitic zoonoses in Nepal: a systematic review.

Authors:  Brecht Devleesschauwer; Anita Ale; Paul Torgerson; Nicolas Praet; Charline Maertens de Noordhout; Basu Dev Pandey; Sher Bahadur Pun; Rob Lake; Jozef Vercruysse; Durga Datt Joshi; Arie H Havelaar; Luc Duchateau; Pierre Dorny; Niko Speybroeck
Journal:  PLoS Negl Trop Dis       Date:  2014-01-02

Review 6.  Mechanisms and pathways of Toxoplasma gondii transepithelial migration.

Authors:  Emily J Jones; Tamas Korcsmaros; Simon R Carding
Journal:  Tissue Barriers       Date:  2016-12-20

7.  Prenatal diagnosis and prevention of toxoplasmosis in pregnant women in Northern Vietnam: study protocol.

Authors:  G Suzanne A Smit; Thi Lam Binh Vu; Trung Dung Do; Niko Speybroeck; Brecht Devleesschauwer; Elizaveta Padalko; Ellen Roets; Pierre Dorny
Journal:  BMC Infect Dis       Date:  2017-05-25       Impact factor: 3.090

8.  The disease burden of congenital toxoplasmosis in Denmark, 2014.

Authors:  Janna Nissen; Pikka Jokelainen; Christen Rune Stensvold; Chiara Trevisan; Josefine Fuchs; Kristoffer Sølvsten Burgdorf; Henrik Vedel Nielsen; Sara M Pires
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

9.  A social cost-benefit analysis of two One Health interventions to prevent toxoplasmosis.

Authors:  Anita W M Suijkerbuijk; Eelco A B Over; Marieke Opsteegh; Huifang Deng; Paul F van Gils; Axel A Bonačić Marinović; Mattijs Lambooij; Johan J Polder; Talitha L Feenstra; Joke W B van der Giessen; G Ardine de Wit; Marie-Josee J Mangen
Journal:  PLoS One       Date:  2019-05-10       Impact factor: 3.240

10.  Immune Mediator Profile in Aqueous Humor Differs in Patients with Primary Acquired Ocular Toxoplasmosis and Recurrent Acute Ocular Toxoplasmosis.

Authors:  Claudia Thieme; Stephan Schlickeiser; Sylvia Metzner; Claudia Dames; Uwe Pleyer
Journal:  Mediators Inflamm       Date:  2019-02-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.